Records containing: Recurrent Adult Brain Tumor

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2017-05-09
A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-grade Gliomas
CLINICAL_TRIALS study record update · 2017-05-03
A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma
CLINICAL_TRIALS study record update · 2017-04-28
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
CLINICAL_TRIALS study record update · 2017-04-17
Early Detection of Glioma Treatment Response Using MRI-Based Biomarkers
CLINICAL_TRIALS study record update · 2017-04-07
A Feasibility Assessment and a Phase I/II Trial of MLN518 for Treatment of Patients With Recurrent Glioblastoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2017-03-20
18F-FDOPA PET/CT or PET/MRI in Patients With Gliomas
CLINICAL_TRIALS study record update · 2017-03-15
A Phase II Trial of GW786034 (Pazopanib) in Patients With Recurrent Glioblastoma
CLINICAL_TRIALS study record update · 2017-02-15
A Phase 1 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
CLINICAL_TRIALS study record update · 2016-11-15
A Phase I-II Trial of Depsipeptide in Patients With Recurrent High-Grade Gliomas
CLINICAL_TRIALS study record update · 2016-04-27
A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme
CLINICAL_TRIALS study record update · 2015-10-02
Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas
CLINICAL_TRIALS study record update · 2015-07-14
Phase I/II Study of R04929097 With Bevacizumab in Patients With Recurrent Malignant Glioma
CLINICAL_TRIALS study record update · 2015-06-15
Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients With Recurrent Malignant Glioma
CLINICAL_TRIALS study record update · 2014-07-10
Phase II Trial of Gliadel Plus 06-Benzylguanine for Patients With Recurrent Glioblastoma Multiforme
CLINICAL_TRIALS study record update · 2014-06-11
Using Proton Magnetic Resonance Spectroscopy (MRS) to Predict Response of Vorinostat Treatment in Glioblastoma
CLINICAL_TRIALS study record update · 2014-06-02
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination With Intravenous Irinotecan in Patients With Recurrent High-Grade Gliomas
CLINICAL_TRIALS study record update · 2014-05-30
Phase I Trial of Aflibercept (VEGF Trap) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Glioma
CLINICAL_TRIALS study record update · 2014-05-30
A Phase I Trial of BAY 43-9006 for Patients With Recurrent or Progressive Malignant Glioma
CLINICAL_TRIALS study record update · 2013-08-22
A Phase II Study of AZD2171 in Recurrent Glioblastoma
CLINICAL_TRIALS study record update · 2013-07-18
A Phase II Study of CCI-779 in Patients With Recurrent Glioblastoma Multiforme
CLINICAL_TRIALS study record update · 2013-07-10
Phase II Trial of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Recurrent Glioblastoma
CLINICAL_TRIALS study record update · 2013-07-10
Phase II Study of Vorinostat (SAHA) in Combination With Bortezomib (PS-341) in Patients With Recurrent Glioblastoma Multiforme
CLINICAL_TRIALS study record update · 2013-06-14
A Randomized Phase II Trial of Bevacizumab to Control Brain Radiation Damage
CLINICAL_TRIALS study record update · 2013-02-07
Phase I Pharmacodynamic and "High Content" Study of the Gamma-Secretase Inhibitor RO4929097 in Patients With Recurrent Malignant Gliomas (MGs) Targeting p75NTR to Inhibit Brain Tumor Initiating Cells (BTICs) and Recurrent Invasive Gliomas
CLINICAL_TRIALS study record update · 2013-01-24
Phase I Evaluation of the Safety of PS 341 in the Treatment of Recurrent Gliomas